Asthma Drugs Market report provides key statistics on the state of the Market and is a valuable source of guidance and direction for companies and individuals interested in the market. The report focuses on global major leading companies providing information such as company profiles, sales, sales revenue, market share and contact information. Finally, the marketing, feasibility of new investment projects is assessed and overall research conclusions offered

An exclusive Asthma Drugs Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

The COVID-19 pandemic diverted resources from healthcare services for patients with diseases such as asthma. COVID-19  causes lung dysfunction, complicating asthma treatment. With an outbreak of COVID-19 in most countries globally, modifications to asthma management have been adopted to accommodate the crisis and minimize the exposure of asthma patients to the infection. As per a research article, International Archives of Allergy and Immunology 2021, the analysis results are in contrast with recently published data from NHS England. In a report of 5,683 COVID-19-linked deaths, the authors reported a higher probability of death in asthmatics with (hazard ratio= 1.25; 95% CI 1.08–1.44) and without corticosteroid use (hazard ratio= 1.11; 95% CI 1.02–1.20).

Request sample pages of this research study at –

The prominent/emerging players in the Asthma Drugs Market research include:

  • AstraZeneca
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Koninklijke Philips NV
  • Sanofi
  • Pfizer Inc.
  • Novartis AG
  • Abbott

Based on route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. In 2021, the inhaled segment held the largest share of the market; however, prefilled syringe/vials segment is estimated to register the highest CAGR of 7.4% in the market during the forecast period. Asthma inhalers are the most popular and effective method of administering asthma medication into the lungs. They come in various shapes and sizes and work in various ways. Some only provide one type of drug, and others have two drugs. There are two types of inhalers, including metered-dose inhalers and dry powder inhalers. A metered-dose inhaler is a device that employs a small aerosol canister to deliver a short burst of medication through a mouthpiece made of plastic. A dry powder inhaler that only releases medicine when you inhale deeply. Moreover, various companies are launching inhalers for the treatment of asthma. For instance, on 15th June 2021, a drug firm named Glenmark Pharma announced the launch of Tiotropium Bromide Fry Powder Inhaler, which is used to treat chronic obstructive pulmonary disease, in the UK. Moreover, Chronic obstructive pulmonary disease (COPD) is a long-term condition that causes inflammation in the lungs, damaged lung tissue, and a narrowing of the airways, making breathing difficult. Glenmark Pharmaceutical is the only company to launch an equivalent version of the Tiotropium Bromide dry powder inhaler under the brand name Tiogiva in the UK for the treatment of COPD.


The table of content for Market research study includes:

  • Introduction
  • Key takeaways
  • Research methodology
  • Market landscape
  • key market dynamics
  • Global market analysis
  • Revenue and forecasts to 2028 – type
  • Revenue and forecasts to 2028 – type of product
  • Revenue and forecasts to 2028 – service
  • Revenue and forecasts to 2028 – geographical analysis
  • Impact of covid-19 pandemic on global market
  • Industry landscape
  • key company profiles
  • Appendix
  • List of tables
  • List of figures



Company overview:

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Product benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

About us:                                                           

The insight partners are a one stop Market research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as semiconductor and electronics, aerospace and defense, automotive and transportation, healthcare it, manufacturing and construction, medical device, technology, media and telecommunications, chemicals and materials.

Contact us:                                                                                                         

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876                                                    

Asia-pacific: +91 20 6727 8686